Rigel Pharmaceuticals Annual Revenue, Number of Employees, Growth and Funding

Overview

Location:
San Francisco, CA Indonesia
Total Funding:N/A
Industry:Biotech
Founded:1996
Lead Investor(s):N/A
Press

Estimated Revenue & Financials

  • Rigel Pharmaceuticals's estimated annual revenue is currently $42M per year.
  • Rigel Pharmaceuticals received $71.8M in venture funding in April 2018.
  • Rigel Pharmaceuticals's estimated revenue per employee is $144,845

Employee Data

  • Rigel Pharmaceuticals has 290 Employees.
  • Rigel Pharmaceuticals grew their employee count by 4% last year.
  • Rigel Pharmaceuticals currently has N/A job openings.

Executive Contacts

NameTitle
Elliott GrossbardExecutive Vice President
Dolly VanceEVP Corporate Affairs/General Counsel
Raul RodriguezPresident and CEO
Brian OlenderSenior Director, Data Acquisition and Systems
Grant LuoDirector Statistical Programming
Michael KacerNational Sales Director
Hua TianAssociate Director, Statistical Programming
Juston EnosRegional Business Director
Nicole TiffanyRegional Business Director-Hem/Onc
Caroline SulaAssociate Director

Rigel Pharmaceuticals, Inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.

keywords:Biotechnology,Cleantech,Healthcare,Pharmaceuticals,Wind Power

290

Number of Employees

$42M

Revenue (est)

N/A

Current Jobs

4%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
DiaCarta
$6.2M4310%N/A
Mission Bio
$10.7M7445%N/A
Rigel Pharmaceu...
$42M2904%N/A
ProTrials Resea...
$26.4M1823%N/A
Trace Genomics
$5.9M4137%N/A
Advanced Cell D...
$25.7M1788%N/A
CellMax Life
$5.7M4011%N/A
Vaxart
$4.2M33-15%N/A
Full Spectrum A...
$6M425%N/A
Calysta
$7.1M49-2%N/A

Rigel Pharmaceuticals News

09/03/2019 - Tempting figures:: Rigel Pharmaceuticals, Inc., (NASDAQ: RIGL)

Each buying and selling session display one-of-a-kind actions and patterns about Rigel Pharmaceuticals, Inc. RIGL), Biotechnology stock.

09/08/2019 - Identifying The Sweet Spot For SINA Corporation (SINA), Rigel Pharmaceuticals (RIGL)

With the previous 100-day trading volume average of 1.32 million shares, Rigel Pharmaceuticals (RIGL) recorded a trading volume of 1.56 ...

09/03/2019 - Acadian Asset Management LLC Increases Stock Holdings in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)

Acadian Asset Management LLC boosted its position in shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) by 548.3% in the second ...

Rigel Pharmaceuticals Funding

DateAmountRoundLead InvestorsReference
2002-01-18$31.5MPublic OfferingArticle
2003-05-01$46.0MLead Investor: MPM CArticle
2003-06-30$46.0MCommon StockMPM CapitalArticle
2003-08-04$9.3MRights OfferingArticle
2009-09-19$108.3MUndisclosedCredit Suisse Securities (USA)Article
2011-05-26$UndisclosedUndisclosedJefferies & Company Inc, J P Morgan Securities LLCArticle
2012-10-04$130.0MUndisclosedJefferies & Company Inc, J P Morgan Securities LLCArticle
2017-02-01$40.0MUndisclosedJefferies LLCArticle
2017-10-04$46.0MUndisclosedJefferies LLCArticle
2017-10-05$69.7MUndisclosedBMO Capital Markets CorpArticle
2018-04-20$71.8MUndisclosedJefferies LLCArticle

Rigel Pharmaceuticals Executive Hires

DateNameTitleReference
2002-10-31Susan ScherVP Strategic RelationsArticle
2003-10-08Robin CooperSVP Pharmaceutical SciencesArticle
2004-06-17Raul RodriguezCOOArticle
2006-06-07Ryan D. MaynardVP Finance/CFOArticle
2008-02-27Daniel B. MagilavyVP Clinical ResearchArticle
2010-06-02Raul RodriguezPresident/COOArticle
2014-11-25Raul RodriguezPresident/COO/CEOArticle
2016-03-09Anne-Marie Duliegechief medical officerArticle
2016-09-16Eldon C. MayerEVP/Chief commercial officerArticle
2016-10-10Esteban MasudaSVP ResearchArticle
2017-12-18Nelson Cabatuaninterim principal accounting officerArticle
2018-05-31Dean SchornoEVP/CFOArticle

Rigel Pharmaceuticals Staff Cuts

DateNumber of EmployeesLocationReference
2009-02-0420 % of StaffArticle
2016-09-1646Article